Clinical Trial Update: Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating the effectiveness and safety of SHR-1314 in psoriatic arthritis. The study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• SHR-1314 (SHR-1314)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED